Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 463-467

  Presta, Ivan ^a   Tassone, E Joseph ^a   Andreozzi, Francesco ^a   Perticone, Maria ^a   Sciacqua, Angela ^a   Laino, Irma ^a   Musca, Donatella ^a   Martino, Francesco ^b   Sesti, Giorgio ^a   Perticone, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angiotensin II; Endothelium; Insulin resistance; Nitric oxide; Receptors

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; STRESS ACTIVATED PROTEIN KINASE; TYROSINE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN METABOLISM; INSULIN RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; CELLS, CULTURED; ENZYME ACTIVATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMIDAZOLES; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LOSARTAN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER; SERINE; SIGNAL TRANSDUCTION; TYROSINE;

EID: 82955239869     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.042     Document Type: Article

References (15)

1. Touyz R.M. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003, 5:155-164.
2. Schelling P., Fischer H., Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy?. J Hypertens 1991, 9:3-15.
3. Touyz R.M., Tabet F., Schiffrin E.L. Redox-dependent signaling by angiotensin II and vascular remodeling in hypertension. Clin Exp Pharmacol Physiol 2003, 30:860-866.
4. Vaughan D.E. Angiotensin, fibrinolysis, and vascular homeostasis. Am J Cardiol 2001, 19:18C-24C.
5. Lijnen P.J., Petrov V.V., Fagard R.H. Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors. J Renin Angiotensin Aldosterone Syst 2001, 2:117-122.
6. Masaki H., Kurihara T., Yamaki A., et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest 1998, 101:527-535.
7. Levy B.I. How to explain the differences between renin angiotensin system modulators. Am J Hypertens 2005, 18:134S-141S.
8. Perticone F., Maio R., Sciacqua A., et al. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension. Diabetes 2008, 57:167-171.
9. Andreozzi F., Laratta E., Sciacqua A., Perticone F., Sesti G. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res 2004, 94:1211-1218.
10. Oishi Y., Ozono R., Yoshizumi M., Akishita M., Horiuchi M., Oshima T. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling. Life Sci 2006, 80:82-88.
11. Xu J., Carretero O.A., Liu Y.H., et al. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hypertension 2002, 40:244-250.
12. Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol 2009, 53:S14-S20.
13. Sjöholm A., Nyström T. Endothelial inflammation in insulin resistance. Lancet 2005, 365:610-612.
14. Igarashi M., Hirata A., Nozaki H., Kadomoto-Antsuki Y., Tominaga M. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats. Diabetes Res Clin Pract 2007, 75:267-277.
15. Horiuchi M., Mogi M., Iwai M. Signaling crosstalk angiotensin II receptor subtypes and insulin. Endocr J 2006, 53:1-5.